Giovanni Teruzzi

Dr. Giovanni Teruzzi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GTGiovanni Teruzzi
Giovanni Teruzzi
GBGiulia Santagostino Baldi
Giulia Santagostino Baldi
SGSebastiano Gili
Sebastiano Gili
GGGianluca Guarnieri
Gianluca Guarnieri
PMPiero Montorsi
Piero Montorsi
Daniela TrabattoniDaniela Trabattoni
Daniela Trabattoni
Myocardial infarction with nonobstructive coronary artery disease due to spontaneous coronary artery dissection (SCAD) accounts for 5–8% of acute coronary syndrome (ACS) presentations. The demographic characteristics, risk factors, and management of patients with SCAD differ from those with atherosclerotic disease. The objective of this review is to provide a contemporary understanding of the epidemiology, pathophysiology, clinical presentation, and management of SCAD.

Verified
Journal Article
Open access
PDF file
SGSebastiano Gili
Sebastiano Gili
GCGiuseppe Calligaris
Giuseppe Calligaris
GTGiovanni Teruzzi
Giovanni Teruzzi
GBGiulia Santagostino Baldi
Giulia Santagostino Baldi
MMManuela Muratori
Manuela Muratori
Daniela TrabattoniDaniela Trabattoni
Daniela Trabattoni
Background: Patent foramen ovale (PFO) is often diagnosed in patients with cryptogenic stroke, aged > 60–65 years, but few data report the outcomes of PFO closure in elderly patients. Methods: Consecutive patients undergoing PFO closure at a single institution between January 2006 and December 2011 were included. Baseline clinical features and cerebral imaging data were collected, and a RoPE score was calculated for each patient. Procedural data were recorded as well as medical therapy upon discharge. All-cause death, ischemic stroke, TIA and systemic embolism recurrence at long-term follow-up were investigated, as well as new atrial fibrillation onset. Results: Overall, 462 patients were included, of whom 64 (13.8%) were aged ≥ 65 years. Female gender was slightly more prevalent in the younger group while hypertension was more frequent among elderly patients. Previous stroke/TIA was the indication for PFO closure in 95.3% of older patients and 80.4% of younger patients, whereas other indications were more frequent among younger patients. RoPE scores were lower in older patients (median RoPE score of 5 vs. 7), and atrial septal aneurysm was more frequently detected among elderly patients. All procedures were technically successful. Procedural or in-hospital complications equally occurred in 5 (7.8%) older patients (4 AF and 1 device embolization) and 30 (7.5%) young patients (29 AF or other supraventricular arrhythmias and 1 device embolization). The follow-up duration was longer among younger patients. All-cause mortality was higher in older patients (16 deaths vs. 4 at follow-up, log-rank p < 0.001), no recurrent strokes occurred, and 2 TIAs were reported among non-elderly patients. New-onset atrial fibrillation occurred in three elderly and eight young patients. Conclusions: PFO closure is a safe procedure in patients aged ≥ 65 years, associated with favorable long-term follow-up and the prevention of ischemic neurologic recurrences.

14 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PNPIOCH Nicolas
PIOCH Nicolas
Daniela TrabattoniDaniela Trabattoni
Daniela Trabattoni
HBHelene Bouvaist
Helene Bouvaist
VEVAUTRIN Estelle
VAUTRIN Estelle
GTGiovanni Teruzzi
Giovanni Teruzzi
AFAlain Fraisse
Alain Fraisse
Background: Transcatheter closure of a patent foramen ovale (PFO) is performed in cryptogenic stroke and other conditions. Information is lacking for some devices. Methods: We aimed to evaluate the Figulla Flex II PFO Occluder (FFP) and Figulla Flex UNI Occluder (FFU) through a retrospective multi-center registry. Results: 527 patients were included. Mean age was 48.9 (±13.8) years. The procedure was under transthoracic, transesophageal or intracardiac echocardiography in 185 (35.1%), 193 (36.6%) and 149 (28.3%) cases, respectively, and under general anesthesia in 191 patients (36.2%). The FFP and FFU were used in 408 (77.4%) and 119 (22.6%) cases, respectively. The success rate was 99.1%. Median follow-up was 1.1 (0.5–2.5) years. A new atrial fibrillation/flutter within six months occurred in 14 (2.7%) cases, with no difference between devices. One device embolization in the pulmonary artery was identified two years post-procedure. Residual shunts occurred in 18 (6.9%) cases at 1 year, with TIA in three (16.6%) patients. Out of 437 patients with stroke/TIA, 260 (59%) were followed more than one year after closure. Median follow-up was 2.1 (1.17–3.1) years, with four recurrent strokes/TIA. Conclusions: The FFP and FFU devices are safe and effective for PFO closure, with very few atrial fibrillation/flutter and neurologic events, except in cases with a residual shunt.

1 February 2019 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
OTOlga Toscano
Olga Toscano
MBMarco Bergonti
Marco Bergonti
GTGiovanni Teruzzi
Giovanni Teruzzi
Daniela TrabattoniDaniela Trabattoni
Daniela Trabattoni

1 August 2016 in Coronary Artery Disease
Verified
Journal Article
Closed access
LGLuca Grancini
Luca Grancini
ALAlessandro Lualdi
Alessandro Lualdi
MBMarouane Boukhris
Marouane Boukhris
GTGiovanni Teruzzi
Giovanni Teruzzi
GMGiovanni Monizzi
Giovanni Monizzi
ABAntonio L. Bartorelli
Antonio L. Bartorelli